X4 Pharmaceuticals Inc (XFOR)
NASDAQ:XFOR

X4 Pharmaceuticals (XFOR) Stock Investors

628 Followers
Based on 651,174 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold XFOR
On average, investors allocate 4.57% of their portfolios to XFOR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 651,174 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding XFOR

3.0%
Last 7
Days
12.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding XFOR, out of 651,174 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

XFOR Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
1.00%
$0.86
Based on the activity of 12,187 investors who made their portfolios public
The table shows changes in XFOR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

XFOR Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Syros Pharmaceuticals
3.85%
-1.12%
-5.60%
$76.82M
Healthcare
Moderna
5.63%
<+0.01%
+0.18%
$49.75B
Healthcare
Twilio
3.15%
+1.51%
+1.57%
$12.35B
Technology
Marvell
4.86%
+1.80%
+7.46%
$51.75B
Technology
DraftKings
6.11%
-0.15%
+0.12%
$21.30B
Technology
Datadog
3.63%
+0.16%
+0.13%
$31.78B
Technology
Applied Materials
4.70%
+1.14%
+3.20%
$113.06B
Technology
General Electric
5.80%
-0.43%
+1.61%
$115.21B
Industrials
Cloudflare
4.19%
+0.14%
+0.47%
$23.45B
Technology
Li Auto
5.38%
+1.07%
+4.72%
$29.22B
Consumer Cyclical
Based on the activity of 651,174 active portfolios
Open your Smart Portfolio

XFOR Investor Analysis

XFOR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.1%
of XFOR holders
are under 35
Average Segment Performance
Average P/E Ratio35.81
Beta4.94
Dividend Yield4.82%
XFOR investors between 35–55

Between 35–55

3.3%
Last 30 days
Holdings Change
51.5%
of XFOR holders
are between 35–55
Average Segment Performance
Average P/E Ratio39.23
Beta4.86
Dividend Yield5.08%
XFOR investors over 55

Over 55

10.7%
Last 30 days
Holdings Change
39.4%
of XFOR holders
are over 55
Average Segment Performance
Average P/E Ratio39.79
Beta0.43
Dividend Yield5.11%
Overview of age group and performance of XFOR stock investors
See who invests in XFOR according to age group and performance.

FAQ

How many retail Investors hold XFOR?
<0.1% of TipRank’s retail investors hold XFOR in their portfolios.
    What is XFOR Investor Sentiment?
    XFOR’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of XFOR in the last 7 days?
      ▲ 3.0% of TipRank’s retail investors changed their holding of XFOR in the last 7 days.
        What percentage of retail investors changed their holding of XFOR in the last 30 days?
        ▲ 12.2% of TipRank’s retail investors changed their holding of XFOR in the last 30 days.
          What is the average age of retail investors who hold XFOR?
          The average age of XFOR Holders is between 35–55.
            What other stocks have XFOR investors also bought?
            XFOR Investors also bought SYRS, MRNA, TWLO, MRVL, DKNG, DDOG, AMAT, GE, NET, LI.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst
              BLRXBioline RX Ltd Sponsored ADR
              BIOBio-Rad Laboratories

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis